DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Early, Effective Control of Graves’ Disease Improves Survival, Regardless of Treatment
An early and intensive control of hyperthyroidism in Graves’ disease is associated with reduced mortality and cardiovascular risk independent of the method of treatment, according to findings from a linked-record cohort study.
“We have shown that patients with Graves’ disease have an increased risk of mortality and cardiovascular disease, which can be reduced by effective and early control of hyperthyroidism,” Onyebuchi Okosieme, MD, FRCP, a consultant endocrinologist with Cwm Taf University Health Board in Wales and an honorary senior research fellow at Cardiff University, United Kingdom, told Endocrine Today. “Patients successfully treated with radioactive iodine in the first year of diagnosis had reduced long-term risk for mortality and major adverse cardiovascular events compared with those treated with antithyroid drugs alone or with those treated with radioiodine without control of hyperthyroidism.”


Related Content
-
Evidence & EducationFailure of Radioactive Iodine in the Treatment of HyperthyroidismBackground: Persistent or recurrent hyp...
-
News & MeetingsLevothyroxine & TPOabsAn interesting read, although the headli...
-
Evidence & EducationFrequency of Flame Sensor Activation in Public Places After Administration of Radioactive Iodine To Treat GravesR...Objective: Ultraviolet (UV)-perception-...
-
Community CenterThyroid Immune Testing – Guidelines, Testing Platforms, and Clinical Impact on Women’s Health: An Expert Panel D...Dr. Rodbard: It is my pleasure to modera...
-
Evidence & EducationTeprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye DiseaseContext: Thyroid eye disease (TED) is a...
-
Evidence & EducationEfficacy and Safety of Mycophenolate Mofetil in Patients With Active Moderate-to-Severe Graves’ OrbitopathyContext: Graves' orbitopathy (GO) is a ...
-
Evidence & EducationGraves’ Disease Pharmacotherapy in Women of Reproductive AgeGraves' disease is an autoimmune disorde...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.